Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief Medical Officer
Press Release 1 March 2021 Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief…
News
DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021
Montrouge, France, March 1, 2020 DBV Technologies to Report Full Year 2020 Financial Results on…
OKYO Pharma Limited (“OKYO” or the “Company”) – Issue of Equity
LONDON, March 01, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (“OKYO” or the “Company”) today…
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference
LONDON and RALEIGH, N.C., March 01, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
Pratteln, Switzerland, March 1, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces positive results from its multiple ascending…
Nicox Announces 2020 Financial Results and 2021 Key Milestones
Press Release Nicox Announces 2020 Financial Results and 2021 Key Milestones Net revenue1 of €12.9…
Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China
— Junshi grants AstraZeneca exclusive promotion rights of toripalimab in mainland China for the urothelial…
Idorsia submits NDA for clazosentan to Japanese PMDA
Allschwil, Switzerland – March 1, 2021 Idorsia Ltd (SIX: IDIA) today announced the submission of…
Orphazyme appoints Christophe Bourdon as Chief Executive Officer
Orphazyme A/SCompany announcement …
BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
Molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that progresses rapidly, results…